IRIV
IRREGULARITY ON INVALIDATION RECEIVED FROM IB
30/12/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Descrição da marca
The mark consists of the wording "TECHDOW". To the left of the wording is a circle with an interior swirl design.
Titulares
Representantes
Charles Ho Barron & Young PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for use in the treatment of headaches; Pharmaceutical preparations, namely, anticoagulants; drugs for medical purposes, namely, diagnostic preparations; biological preparations for medical purposes for the treatment of cancer; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations in the nature of injections containing enoxaparin sodium, dalteparin sodium, and nadroparin sodium for use in the treatment of heart disease; allergy, antibiotic tablets; Drug delivery agents in the form of powders that provide controlled release of active ingredients, namely, enoxaparin sodium, dalteparin sodium, and nadroparin sodium for a wide variety of pharmaceuticals; biochemical drug, namely, anti-diabetic pharmaceuticals
Classe 10
Hypodermic syringes; medical apparatus and instruments for treating cardiovascular disease, use in orthopedic surgery; [physical exercise apparatus, for medical purposes; dental apparatus, namely, dental drills; radiotherapy apparatus; furniture especially made for medical purposes; contraceptives, non-chemical; ] surgical implants comprising artificial materials [ ; electrical weight loss body belts; surgical thread ]
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
IRREGULARITY ON INVALIDATION RECEIVED FROM IB
30/12/2025
GENERIC MADRID TRANSACTION SENT TO IB
24/11/2025
GENERIC MADRID TRANSACTION CREATED
24/11/2025
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
21/06/2025
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
21/10/2024
REGISTERED-SEC.71 ACCEPTED
21/10/2024
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/09/2024
TEAS SECTION 71 RECEIVED
01/02/2024
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/03/2023
INTERNATIONAL REGISTRATION RENEWED
09/12/2022
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
27/04/2020
REGISTERED-SEC.71 ACCEPTED
27/04/2020
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/04/2020
TEAS SECTION 71 RECEIVED
11/03/2020
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/05/2015
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
30/11/2014
FINAL DECISION TRANSACTION PROCESSED BY IB
12/07/2014
FINAL DISPOSITION NOTICE SENT TO IB
25/06/2014
FINAL DISPOSITION PROCESSED
25/06/2014
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/06/2014
CORRECTION UNDER SECTION 7 - PROCESSED
30/03/2014
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/03/2014
CHANGE OF NAME/ADDRESS REC'D FROM IB
27/03/2014
SEC 7 REQUEST FILED
16/03/2014
TEAS SECTION 7 REQUEST RECEIVED
16/03/2014
REGISTERED-PRINCIPAL REGISTER
11/03/2014
NOTIFICATION PROCESSED BY IB
24/12/2013
PUBLISHED FOR OPPOSITION
24/12/2013
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/12/2013
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/12/2013
NOTICE OF PUBLICATION
04/12/2013
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/11/2013
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/11/2013
ASSIGNED TO LIE
19/11/2013
APPROVED FOR PUB - PRINCIPAL REGISTER
30/10/2013
TEAS/EMAIL CORRESPONDENCE ENTERED
29/10/2013
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/10/2013
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/10/2013
REFUSAL PROCESSED BY IB
19/06/2013
APPLICATION FILING RECEIPT MAILED
01/06/2013
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/05/2013
REFUSAL PROCESSED BY MPU
29/05/2013
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/05/2013
NON-FINAL ACTION WRITTEN
28/05/2013
ASSIGNED TO EXAMINER
28/05/2013
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/05/2013
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/05/2013
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.